ArticleCancer medicine2026

Co-Mutation of ASXL1 and KRAS Defines a Novel Ultra-Adverse-Risk Subtype of Acute Myeloid Leukemia in a Large-Scale Cohort.

Yijing Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.